feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

SSC CGL Tier 1 result

trending

Akhanda 2 release postponed

trending

RBI likely to hold rate

trending

IRCTC online ticket bookings increase

trending

Indigo flight cancellations pilot rules

trending

USA World Cup 2026

trending

Drugs bust like Breaking Bad

trending

Game of Thrones spin-off renewed

trending

India South Africa security blanket

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Japan's AI Health Tech Shines in India

Japan's AI Health Tech Shines in India

4 Dec

•

Summary

  • CarbGeM CEO presented AI solutions at India's premier health summit.
  • Japan's medical innovations showcased to foster collaboration.
  • AI diagnostics and AMR solutions highlighted for global impact.
Japan's AI Health Tech Shines in India

At the 22nd CII Annual Health Summit 2025 in New Delhi, CarbGeM CEO Masakazu Nakajima presented cutting-edge Japanese healthcare AI solutions. The summit, a leading international healthcare conference, convened key stakeholders to discuss the future of health under the "Viksit Bharat @2047" theme. Nakajima's presentation underscored the growing Japan-India collaboration in the healthcare sector.

During the "2nd MEJ-India Seminar: Showcasing Japan Healthcare Innovations," CarbGeM showcased its AI-powered diagnostic support and biomanufacturing workflow DX. Solutions like CarbConnect® and BiTTE® were highlighted for their ability to address global Antimicrobial Resistance (AMR) challenges and enhance medical access.

CarbGeM's participation aimed to demonstrate how Japanese healthcare AI can elevate care quality and support evidence-based decisions in clinical and industrial fields. The company, known for its regulatory-approved AI platforms, seeks to solve social challenges by enabling fast, accurate decision-making.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
CEO Masakazu Nakajima presented CarbGeM's AI-driven solutions, including AI image analysis and microbial morphology estimation software, for infectious disease diagnostics and biomanufacturing.
The "Japan Connect" program highlights Japanese healthcare innovations and aims to foster collaboration between Japan and India in the medical device, pharmaceutical, and digital health sectors.
CarbGeM's AI platforms are designed to improve medical access, enhance care quality, and support evidence-based decision-making, particularly in addressing global Antimicrobial Resistance (AMR) challenges.

Read more news on

Indiaside-arrowHealthside-arrowNew Delhiside-arrow

You may also like

India Patents AI Tech Predicting Food's Sugar Impact

1 day ago • 2 reads

article image

Swaraj Kaushal, 73, Passes Away After Chest Pain

1 day ago • 9 reads

article image

Heart Attacks Surge: Government Lacks Central Data

3 Dec • 12 reads

article image

RNA Breakthrough Targets Heavy Periods for Underserved Women

30 Nov • 23 reads

article image

Biotech Chief Proposes Drug Approval Overhaul

24 Nov • 38 reads

article image